Skip to main content
PMC home page
Springer Nature - PMC COVID-19 Collection logoLink to Springer Nature - PMC COVID-19 Collection
. 1998;2(3):213–220. doi: 10.1023/A:1009829712638

The Effects of Granulocyte Colony-Stimulating Factor (G-CSF) in Pre-Clinical Models of Infection and Acute Inflammation

John C Marshall 1
PMCID: PMC7144475  PMID: 32288620

The content is available as a PDF (132.7 KB).

References

  • 1.Abraham E, Stevens P. Effects of granulocyte colony stimulating factor in modifying mortality from Pseudomonas aeruginosa pneumonia after hemorrhage. Crit Care Med. 1992;20:1127–1133. doi: 10.1097/00003246-199208000-00011. [DOI] [PubMed] [Google Scholar]
  • 2.Anderlini P, Przepiorka D, Champlin R, Körbling M. Biologic and clinical effects of granulocyte colony-stimulating factor in normal individuals. Blood. 1996;88:2819–2825. [PubMed] [Google Scholar]
  • 3.Avalos BR. Molecular analysis of the granulocyte colony-stimulating factor receptor. Blood. 1996;88:761–777. [PubMed] [Google Scholar]
  • 4.Barsig J, Bundschuh DS, Hartung T, Bauhofer A, Sauer A, Wendel A. Control of fecal peritoneal infection in mice by colony-stimulating factors. J Infect Dis. 1996;174:790–799. doi: 10.1093/infdis/174.4.790. [DOI] [PubMed] [Google Scholar]
  • 5.Bradley TR, Metcalf D. The growth of mouse bone marrow cells in vitro. Aust J Exp Biol Med Sci. 1966;44:287–294. doi: 10.1038/icb.1966.28. [DOI] [PubMed] [Google Scholar]
  • 6.Buisman AM, Langermans JA, Van Furth R. Effect of granulocyte colony-stimulating factor on the course of infection with Gram positive bacteria in mice during granulocytopenia induced by sublethal irradiation or cyclophosphamide. J Infect Dis. 1996;174:417–421. doi: 10.1093/infdis/174.2.417. [DOI] [PubMed] [Google Scholar]
  • 7.Cairo MS, Plunkett JM, Mauss D, Van de Ven C. Seven-day administration of recombinant human granulocyte colony-stimulating factor to newborn rats: Modulation of neonatal neutrophilia, myelopoiesis, and Group B Streptococcus sepsis. Blood. 1990;76:1788–1794. [PubMed] [Google Scholar]
  • 8.Cebon J, Layton J, Maher D, Morstyn G. Endogenous hematopoietic growth factors in neutropenia and infection. Br J Haematol. 1994;86:274. doi: 10.1111/j.1365-2141.1994.tb04725.x. [DOI] [PubMed] [Google Scholar]
  • 9.Dale DC, Liles WC, Summer WR, Nelson S. Review: Granulocyte colony-stimulating factor role and relationships in infectious diseases. J Infect Dis. 1995;172:1075. doi: 10.1093/infdis/172.4.1061. [DOI] [PubMed] [Google Scholar]
  • 10.DeMarsh PL, Sucolski SK, Frey CL, Bhatnagar PK, Koltin Y, Actor P, Petteway SR. Efficacy of the hematoregulatory peptide SK&F 107647 in experimental Candida albicans infections in normal and immunosuppressed mice. Immunopharm. 1994;27:199–206. doi: 10.1016/0162-3109(94)90016-7. [DOI] [PubMed] [Google Scholar]
  • 11.Dunne JR, Dunkin BJ, Nelson S, White JC. Effects of granulocyte colony stimulating factor in a nonneutropenic rodent model of Escherichia coli peritonitis. J Surg Res. 1996;61:348–354. doi: 10.1006/jsre.1996.0128. [DOI] [PubMed] [Google Scholar]
  • 12.Eaves-Pyles T, Alexander JW. Granulocyte colony-stimulating factor enhances killing of translocated bacteria but does not affect barrier function in a burn mouse model. J Trauma. 1996;41:1013–1017. doi: 10.1097/00005373-199612000-00012. [DOI] [PubMed] [Google Scholar]
  • 13.Eichacker PQ, Waisman Y, Natanson C, Farese A, Hoffman WD, Banks SM, Macvittie TJ. Cardiopulmonary effects of granulocyte colony-stimulating factor in a canine model of bacterial sepsis. J Appl Physiol. 1994;77:2366–2373. doi: 10.1152/jappl.1994.77.5.2366. [DOI] [PubMed] [Google Scholar]
  • 14.Fink MP, O'Sullivan BP, Menconi MJ, Wollert SP, Wang H, Youssef ME, Bellelsle JM. Effect of granulocyte colony-stimulating factor on systemic and pulmonary responses to endotoxin in pigs. J Trauma. 1993;34:571–578. doi: 10.1097/00005373-199304000-00015. [DOI] [PubMed] [Google Scholar]
  • 15.Freeman BD, Correa R, Karzai W, et al. Controlled trials of rG-CSF and CD11b-directed MAb during hyperoxia and E. coli pneumonia in rats. J Appl Physiol. 1996;80:2066–2076. doi: 10.1152/jappl.1996.80.6.2066. [DOI] [PubMed] [Google Scholar]
  • 16.Freeman BD, Quezado Z, Zeni F, et al. rG-CSF reduces endotoxemia and improves survival during E. coli pneumonia. J Appl Physiol. 1997;83:1467–1475. doi: 10.1152/jappl.1997.83.5.1467. [DOI] [PubMed] [Google Scholar]
  • 17.Gorgen I, Hartung T, Leist M, et al. Granulocyte colony-stimulating factor treatment protects rodents against lipopolysaccharde-induced toxicity via suppression of systemic tumor necrosis factor-alpha. J Immunol. 1992;149:918–924. [PubMed] [Google Scholar]
  • 18.Goya T, Torisu M, Doi F, Yoshida T. Effects of granulocyte colony-stimulating factor and monobactam antibiotics (Aztreonam) on neutrophil functions in sepsis. Clin Immunol Immunopathol. 1993;69:278–284. doi: 10.1006/clin.1993.1181. [DOI] [PubMed] [Google Scholar]
  • 19.Graybill JR, Bocanegra R, Luther M. Antifungal combination therapy with granulocyte colony-stimulating factor and fluconazole in experimental disseminated Candidiasis. Eur J Clin Microbiol Infect Dis. 1995;14:700–703. doi: 10.1007/BF01690878. [DOI] [PubMed] [Google Scholar]
  • 20.Haberstroh J, Breuer H, Lucke l., et al. Effect of recombinant human granulocyte colony-stimulating factor on hemodynamic and cytokine response in a porcine model of Pseudomonas sepsis. Shock. 1995;4:216–224. doi: 10.1097/00024382-199509000-00011. [DOI] [PubMed] [Google Scholar]
  • 21.Haberstroh J, Wiese K, Geist A, et al. Effect of delayed treatment with recombinant human granulocyte colony-stimulating factor on survival and plasma cytokine levels in a non-neutropenic porcine model of Pseudomonas aeruginosa sepsis. Shock. 1998;9:128–134. doi: 10.1097/00024382-199802000-00009. [DOI] [PubMed] [Google Scholar]
  • 22.Hamood M, Bluche PF, De Vroey C, Corazza F, Bujan W, Fondu P. Effects of recombinant human granulocyte colony-stimulating factor on neutropenic mice infected with Candida albicans: acceleration of recovery from neutropenia and potentiation of anti-C. albicans resistance. Mycoses. 1994;37:93–99. doi: 10.1111/j.1439-0507.1994.tb00783.x. [DOI] [PubMed] [Google Scholar]
  • 23.Hanaoka M, Kubo K, Miyahara T, Hayano T, Koizumi T, Kobayashi T, Sekiguchi M. Effect of post-treatment with granulocyte colony-stimulating factor on endotoxin-induced lung injury in sheep. Exp Lung Res. 1998;24:15–25. doi: 10.3109/01902149809046051. [DOI] [PubMed] [Google Scholar]
  • 24.Heard SO, Fink MP, Gamelli RL, et al. The Filgrastim Study Group. Effect of prophylactic administration of recombinant human granulocyte colony-stimulating factor (filgrastim) on the frequency of nosocomial infections in patients with acute traumatic brain injury or cerebral hemorrhage. Crit Care Med. 1998;26:748–754. doi: 10.1097/00003246-199804000-00027. [DOI] [PubMed] [Google Scholar]
  • 25.Hebert JC, O'Reilly M, Barry B, Shatney L, Sartorelli K. Effects of exogenous cytokines on intravascular clearance of bacteria in normal and splenectomized mice. J Trauma. 1997;43:875–879. doi: 10.1097/00005373-199712000-00001. [DOI] [PubMed] [Google Scholar]
  • 26.Held TK, Mielke ME, Chedid M, Unger M, Trautmann M, Huhn D, Cross AS. Granulocyte colony-stimulating factor worsen the outcome of experimental Klebsiella pneumoniae pneumonia through direct interaction with the bacteria. Blood. 1998;91:2525–2535. [PubMed] [Google Scholar]
  • 27.Hustinx W, Benaissa-Trouw B, Van Kessel K, et al. Granulocyte colony-stimulating factor enhances protection by anti-K1 capsular lgM antibody in murine Escherichia coli sepsis. Eur J Clin Invest. 1997;27:1044–1048. doi: 10.1046/j.1365-2362.1997.2290787.x. [DOI] [PubMed] [Google Scholar]
  • 28.Ichikawa Y, Pluznik DH, Sachs RJ. In vitro control of the development of macrophage and granulocyte colonies. Proc Natl Acad Sci USA. 1966;56:495. doi: 10.1073/pnas.56.2.488. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Iguchi K, Inoue S, Kmar A. Effect of recombinant human granulocyte colony-stimulating factor administration in normal and experimentally infected newborn rats. Exp Hematol. 1991;19:352–358. [PubMed] [Google Scholar]
  • 30.Ishikawa K, Tanaka H, Matsuoka T, Shimazu T, Yoshioka T, Sugimoto H. Recombinant human granulocyte colony-stimulating factor attenuates inflammatory responses in septic patients with neutropenia. J Trauma. 1998;44:1047–1054. doi: 10.1097/00005373-199806000-00018. [DOI] [PubMed] [Google Scholar]
  • 31.Kanazawa M, Ishizaka A, Hasegawa N, Suzuki Y, Yokoyama T. Granulocyte colony-stimulating factor does not enhance endotoxin-induced acute lung injury in guinea pigs. Am Rev Respir Dis. 1992;145:1030–1035. doi: 10.1164/ajrccm/145.5.1030. [DOI] [PubMed] [Google Scholar]
  • 32.Kawakami M, Tsutsumi H, Kumakawa T, et al. Levels of serum granulocyte colony-stiulating factor in patients with infections. Blood. 1990;78:3254–3258. [PubMed] [Google Scholar]
  • 33.Kayashima S, Tsuruu S, Hata N, Rokutanda M. Therapeutic effect of granulocyte colony-stimulating factor (G-CSF) on the protection against Listeria infection in SCID mice. Immunology. 1993;80:471–476. [PMC free article] [PubMed] [Google Scholar]
  • 34.King J, Deboisblanc BP, Mason CM, et al. Effect of granulocyte colony-stimulating factor on acute lung injury in the rat. Am J Resp Crit Care Med. 1995;151:302–309. doi: 10.1164/ajrccm.151.2.7531097. [DOI] [PubMed] [Google Scholar]
  • 35.Koike K, Moore FA, Moore EE, Poggetti RS, Tuder RM, Banerjee A. Endotoxin after gut ischemia/reperfusion causes irreversible lung injury. J Surg Res. 1992;52:656–662. doi: 10.1016/0022-4804(92)90145-p. [DOI] [PubMed] [Google Scholar]
  • 36.Koizumi T, Kubo K, Shinozaki S, Koyama S, Kobayashi T, Sekiguchi M. Granulocyte colony-stimulating factor does not exacerbate endotoxin-induced lung injury in sheep. Am Rev Respir Dis. 1993;148:132–137. doi: 10.1164/ajrccm/148.1.132. [DOI] [PubMed] [Google Scholar]
  • 37.Kullberg B-J, Netea MG, Curfs JH, Keuter M, Meis JF, van der Meer JW. Recombinant murine granulocyte colony-stimulating factor protects against acute disseminated Candida albicans infection in nonneutropenic mice. J Infect Dis. 1998;177:175–181. doi: 10.1086/513812. [DOI] [PubMed] [Google Scholar]
  • 38.Lister PD, Gentry MJ, Preheim LC. Granulocyte colony-stimulating factor protects control rats but not ethanol-fed rats from fatal pneumococcal pneumonia. J Infect Dis. 1993;168:922–926. doi: 10.1093/infdis/168.4.922. [DOI] [PubMed] [Google Scholar]
  • 39.Liu F, Poursine-Laurent J, Link DC. The granulocyte colony-stimulating factor receptor is required for the mobilization of murine hematopoietic progenitors into peripheral blood by cyclophoshamide or interleukin-8 but not flt-3 ligand. Blood. 1997;90:2522–2528. [PubMed] [Google Scholar]
  • 40.Lorenz W, Reimund K-P, Weitzel F, et al. Granulocyte colony-stimulating factor prophylaxis before operation protects against lethal consequences of postoperative peritonitis. Surgery. 1994;116:925–934. [PubMed] [Google Scholar]
  • 41.Lundblad R, Nesland JM, Giercksky KE. Granulocyte colony-stimulating factor improves survival rate and reduces concentrations of bacteria, endotoxin, tumor necrosis factor, aned endothelin-1 in fulminant intra-abdominal sepsis in rats. Crit Care Med. 1996;24:820–826. doi: 10.1097/00003246-199605000-00016. [DOI] [PubMed] [Google Scholar]
  • 42.Lundblad R, Wang MY, Kvalheim G, Lingaas E, Giercksky KE. Granulocyte colony-stimulating factor improves myelopoiesis and host defense in fulminant intra-abdominal sepsis in rats. Shock. 1995;4:68–73. doi: 10.1097/00024382-199507000-00011. [DOI] [PubMed] [Google Scholar]
  • 43.Matsumoto M, Matsubara S, Yokota T. Effect of combination therapy with recombinant human granulocyte colony-stimulating factor (r G-CSF) and antibiotics in neutropenic mice unresponsive to antibiotics alone. J Antimicrob Chemother. 1991;28:447–453. doi: 10.1093/jac/28.3.447. [DOI] [PubMed] [Google Scholar]
  • 44.Muranaka H, Suga M, Nakagawa K, Sato K, Gushima Y, Ando M. Effects of granulocyte ad granulocyte-macrophage colony-stimulating factors in a neutropenic murine model of trichosporonosis. Infect Immun. 1997;65:3422–3429. doi: 10.1128/iai.65.8.3422-3429.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Nelson S, Bagby GJ. Granulocyte colony-stimulating factor and modulation of inflammatory cells in sepsis. Clin Chest Med. 1996;17:319–332. doi: 10.1016/s0272-5231(05)70317-8. [DOI] [PubMed] [Google Scholar]
  • 46.Nicola NA, Metcalf D, Matsumoto M, Johnson GR. Purification of a factor inducing differentiation in murine myelomonocytic leukemia cells. J Biol Chem. 1983;258:9017–9023. [PubMed] [Google Scholar]
  • 47.Novales JS, Salva AM, Modanlou HD, Kaplan DL, del Castillo J, Anderson J, Medlock ES. Maternal administration of granulocyte colony-stimulating factor improves neonatal rat survival after lethal group B Streptococcal infection. Blood. 1993;81:923–927. [PubMed] [Google Scholar]
  • 48.O'Reilly M, Silver GM, Greenhalgh DG, Gamelli RL, Davis JH, Hebert JC. Treatment of intra-abdominal infection with granulocyte colony-stimulating factor. J Trauma. 1992;33:679–682. doi: 10.1097/00005373-199211000-00014. [DOI] [PubMed] [Google Scholar]
  • 49.Pajkrt D, Manten A, van der Poll T, et al. Modulation of cytokine release and neutrophil function by granulocyte colony-stimulating factor during endotoxemia in humans. Blood. 1997;90:1415–1424. [PubMed] [Google Scholar]
  • 50.Patton JH, Jr, Lyden SP, Rgasdale DN, Croce MA, Fabian TC, Proctor KG. Granulocyte colony-stimulating factor improves host defense to resuscitated shock and polymicrobial sepsis without provoking generalized neutrophil-mediated damage. J Trauma. 1998;44:750–758. doi: 10.1097/00005373-199805000-00002. [DOI] [PubMed] [Google Scholar]
  • 51.Piper RD, Cook DJ, Bone RC, Sibbald WJ. Introducing Critical Appraisal to studies of animal models investigating novel therapies in sepsis. Crit Care Med. 1996;24:2059–2070. doi: 10.1097/00003246-199612000-00021. [DOI] [PubMed] [Google Scholar]
  • 52.Polak-Wyss A. Protective effect of human granulocyte colony-stimulating factor (h G-CSF) on Candida infections in normal and immunosuppressed mice. Mycoses. 1991;34:109–118. doi: 10.1111/j.1439-0507.1991.tb00630.x. [DOI] [PubMed] [Google Scholar]
  • 53.Polmächer T, Korth C, Mullington J, et al. Effects of granulocyte colony-stimulating factor on plasma cytokine and cytokine receptor levels and on the in vivo host response to endotoxin in healthy men. Blood. 1996;87:900. [PubMed] [Google Scholar]
  • 54.Preheim LC, Snitily MU, Gentry MJ. Effects of granulocyte colony-stimulating factor in cirrhotic rats with pneumococcal pneumonia. J infect Dis. 1996;174:225–228. doi: 10.1093/infdis/174.1.225. [DOI] [PubMed] [Google Scholar]
  • 55.Rao R, Prinz RA, Kazantsev GB, et al. Effects of granulocyte colony-stimulating factor in severe pancreatitis. Surgery. 1996;119:657–663. doi: 10.1016/s0039-6060(96)80190-5. [DOI] [PubMed] [Google Scholar]
  • 56.Schilero GJ, Oropello J, Benjamin E. Impairment in gas exchange after granulocyte colony stimulating factor (G-CSF) in a patient with the adult respiratory distress syndrome. Chest. 1995;107:276–278. doi: 10.1378/chest.107.1.276. [DOI] [PubMed] [Google Scholar]
  • 57.Serushago BA, Yoshikai Y, Handa T, Mitsuyama M, Muramori K, Nomoto K. Effect of recombinant human granulocyte colony-stimulating factor (rh G-CSF) on murine resistance against Listeria monocytogenes. Immunology. 1992;75:475–480. [PMC free article] [PubMed] [Google Scholar]
  • 58.Seymour JF, Lieschke GJ, Grail D, Quillici C, Hodgson G, Dunn AR. Mice lacking both granulocyte colony-stimulating factor (CSF) and granulocyte macrophage CSF have impaired reproductive capacity, perturbed neonatal granulopoiesis, lung disease, amyloidosis, and redced long term survival. Blood. 1997;90:3037–3049. [PubMed] [Google Scholar]
  • 59.Shinomiya N, Tsuru S, Katsura Y, Kayashima S, Nomoto K. Enhanced resistance against Listeria monocytogenes achieved by pretreatment with granulocyte colony-stimulating factor. Infect Immun. 1991;59:4740–4743. doi: 10.1128/iai.59.12.4740-4743.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Shirai R, Kadoto T, Tomono K, Ogawa K, lida K, Kawakami K, Kohno S. Protective effect of granulocyte colony-stimulating factor (G-CSF) in a granulocytopenic mouse model of Pseudomonas aeruginosa lung infection through enhanced phagocytosis and killing by alveolar macrophages through priming tumor necrosis factor α (TNF-α) production. Clin exp Immunol. 1997;109:73–79. doi: 10.1046/j.1365-2249.1997.4211317.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Smith WS, Sumnicht GE, Sharpe RW, Samuelson D, Millard FE. Granulocyte colony-stimulating factor versus placebo in addition to penicillin G in a randomized blinded study of gram-negative pneumonia sepsis: Analysis of survival and multisystem organ failure. Blood. 1995;86:1301–1309. [PubMed] [Google Scholar]
  • 62.Steinshamn S, Bergh K, Waage A. Effects of stem cell factor and granulocyte colony-stimulating factor on granulocyte recovery and Candida albicans infection in granulocytopenic mice. J Infect Dis. 1993;168:1444–1448. doi: 10.1093/infdis/168.6.1444. [DOI] [PubMed] [Google Scholar]
  • 63.Terashima T, Kanazawa M, Sayama K, et al. Granulocyte colony-stimulating factor exacerbates acute lung injury induced by intratracheal endotoxin in guinea pigs. Am J Resp Crit Care Med. 1994;149:1295–1303. doi: 10.1164/ajrccm.149.5.7513596. [DOI] [PubMed] [Google Scholar]
  • 64.Tian S-S, Lamb P, King AG, et al. A small, nonpeptidyl mimic of granulocyte colony-stimulating factor. Science. 1998;281:257–259. doi: 10.1126/science.281.5374.257. [DOI] [PubMed] [Google Scholar]
  • 65.Toda H, Murata A, Matsuura N, Uda K, Oka Y, Tanaka N, Mori T. Therapeutic efficacy of granulocyte colony stimulating factor against rat cecal ligation and puncture model. Stem Cells. 1993;11:228–234. doi: 10.1002/stem.5530110310. [DOI] [PubMed] [Google Scholar]
  • 66.Uchida K, Yamamoto Y, Klein TW, Friedman H, Yamaguchi H. Granulocyte colony-stimulating factor facilities the restoration of residence to opportunistic fungi in leukopenic mice. J Med Vet Mycol. 1992;30:293–300. doi: 10.1080/02681219280000381. [DOI] [PubMed] [Google Scholar]
  • 67.Vollmar B, Messner S, Wanner GA, Hartung T, Menger MD. Immunomodulatory ation of G-CSF in a rat model of endotoxin-induced liver injury: An intravital microscopic analysis of Kupffer cell and leukocyte response. J Leuk Biol. 1997;62:710–718. doi: 10.1002/jlb.62.6.710. [DOI] [PubMed] [Google Scholar]
  • 68.Wakiyama H, Tsuru S, Hata N, et al. Therapeutic effect of granulocyte colony-stimulating factor and cephem antibiotics against experimental infections in neutropenic mice induced by cyclophosphamide. Clin Exp Immunol. 1993;92:218–224. doi: 10.1111/j.1365-2249.1993.tb03383.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69.Zhang P, Bagby GJ, Stoltz DA, Spitzer JA, Summer WR, Nelson S. Modulation of the lung host response by granulocyte colony-stimulating factor in rats challenged with intrapulmonary endotoxin. Shock. 1997;7:193–199. doi: 10.1097/00024382-199703000-00007. [DOI] [PubMed] [Google Scholar]

Articles from Sepsis are provided here courtesy of Nature Publishing Group

RESOURCES